GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
Pearson, M, Carbone, R, Sebastiani, C, Cioce, M, Fagioli, M, Saito, S, Higashimoto, Y, Appella, E, Minucci, S, Pandolfi, PP and Pelicci, PG (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207-10
The tumour suppressor p53 induces cellular senescence in response to oncogenic signals. p53 activity is modulated by protein stability and post-translational modification, including phosphorylation and acetylation. The mechanism of p53 activation by oncogenes remains largely unknown. Here we report that the tumour suppressor PML regulates the p53 response to oncogenic signals. We found that oncogenic Ras upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner. p53 is acetylated at lysine 382 upon Ras expression, an event that is essential for its biological function. Ras induces re-localization of p53 and the CBP acetyltransferase within the PML nuclear bodies and induces the formation of a trimeric p53-PML-CBP complex. Lastly, Ras-induced p53 acetylation, p53-CBP complex stabilization and senescence are lost in PML-/- fibroblasts. Our data establish a link between PML and p53 and indicate that integrity of the PML bodies is required for p53 acetylation and senescence upon oncogene expression.
Acetylation; Animals; Cell Aging/genetics; Cell Aging/physiology; Cell Nucleus/metabolism; Genes, ras; Humans; Lysine/metabolism; Mice; Neoplasm Proteins/metabolism; Neoplasm Proteins/physiology; Nuclear Proteins/metabolism; Nuclear Proteins/physiology; Signal Transduction; Transcription Factors/metabolism; Transcription Factors/physiology; Tumor Suppressor Protein p53/metabolism; Tumor Suppressor Proteins; Up-Regulation
|Gene product||Qualifier||GO ID||GO term name||Evidence Code||with/from||Aspect||Notes||Status|
See Help:References for how to manage references in GONUTS.